Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Female hair loss linked to metabolic syndrome, not in males.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Human hair varies widely and should be classified by curl type rather than race.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Mild exercise reduces pain in older rats through a brain chemical, while intense exercise reduces pain in all rats through a different pain-blocking process.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Skin diseases in Turkish children vary by age and gender, with infections, eczema, acne, and allergies most common.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.